Omega-3 supplements taken before and after surgery actually helped – RCT Nov 2018

Fish Oil and Perioperative Bleeding – Insights From the OPERA Randomized Trial

Cardiovascular Quality and Outcomes. 2018;11:e004584
Emmanuel Akintoye , Prince Sethi , William S. Harris , Paul A. Thompson , Roberto Marchioli , Luigi Tavazzi , Roberto Latini , Mias Pretorius , Nancy J. Brown , Peter Libby , Dariush Mozaffarian

Background
Fish oil is among the most common natural supplements for treatment of hypertriglyceridemia or prevention of cardiovascular disease. However, concerns about theoretical bleeding risk have led to recommendations that patients should stop taking fish oil before surgery or delay in elective procedures for patients taking fish oil by some health care professionals.

Methods and Results
We tested the effect of fish oil supplementation on perioperative bleeding in a multinational, placebo-controlled trial involving 1516 patients who were randomized to perioperative fish oil (eicosapentaenoic acid+docosahexaenoic acid; 8–10 g for 2–5 days preoperatively, and then 2 g/d postoperatively) or placebo.
Primary outcome was major perioperative bleeding as defined by the Bleeding Academic Research Consortium.
Secondary outcomes include perioperative bleeding per thrombolysis in myocardial infarction and International Society on Thrombosis and Hemostasis definitions, chest tube output, and total units of blood transfused. Participants’ mean (SD) age was 63 (13) years, and planned surgery included coronary artery bypass graft (52%) and valve surgery (50%). The primary outcome occurred in 92 patients (6.1%).
Compared with placebo, risk of Bleeding Academic Research Consortium bleeding was not higher in the fish oil group: odds ratio, 0.81; 95% CI, 0.53–1.24; absolute risk difference, 1.1% lower (95% CI, −3.0% to 1.8%).
Similar findings were seen for secondary bleeding definitions. The total units of blood transfused were significantly lower in the fish oil group compared with placebo (mean, 1.61 versus 1.92; P<0.001).
Evaluating achieved plasma phospholipid omega-3 polyunsaturated fatty acids levels with supplementation (on the morning of surgery), higher levels were associated with lower risk of Bleeding Academic Research Consortium bleeding, with substantially lower risk in the third (odds ratio, 0.30 [95% CI, 0.11–0.78]) and fourth (0.36 [95% CI, 0.15–0.87]) quartiles, compared with the lowest quartile.

Conclusions
Fish oil supplementation did not increase perioperative bleeding and reduced the number of blood transfusions. Higher achieved n-3-PUFA levels were associated with lower risk of bleeding. These novel findings support the need for reconsideration of current recommendations to stop fish oil or delay procedures before cardiac surgery.

Clinical Trial Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT00970489.

References

• 45. Health Sciences Institute. These Excellent Supplements Need to be Sidelined before Surgery.http://hsionline.com/2013/10/07/the-most-dangerous-supplements/. Accessed January 14, 2018.
• 52. Del Brutto OH, Mera RM, Ha JE, Del Brutto VJ, Castillo PR, Zambrano M, Gillman J. Oily fish consumption is inversely correlated with cerebral microbleeds in community-dwelling older adults: results from the Atahualpa Project.Aging Clin Exp Res. 2016;28:737–743. doi: 10.1007/s40520-015-0473-6
• 54. Kepler CK, Huang RC, Meredith D, Kim JH, Sharma AK. Omega-3 and fish oil supplements do not cause increased bleeding during spinal decompression surgery.J Spinal Disord Tech. 2012;25:129–132. doi: 10.1097/BSD.0b013e3182120227

• 1. Lavie CJ, Milani RV, Mehra MR, Ventura HO. Omega-3 polyunsaturated fatty acids and cardiovascular diseases.J Am Coll Cardiol. 2009;54:585–594. doi: 10.1016/j.jacc.2009.02.084
• 2. Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events.J Am Coll Cardiol. 2011;58:2047–2067. doi: 10.1016/j.jacc.2011.06.063
• 3. Clarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL. Trends in the use of complementary health approaches among adults: United States, 2002–2012.Natl Health Stat Report. 2015;79:1–16.
• 4. Singh SR, Levine MA. Potential interactions between pharmaceuticals and natural health products in Canada.J Clin Pharmacol. 2007;47:249–258. doi: 10.1177/0091270006296421
• 5. Calder PC. Mechanisms of action of (n-3) fatty acids.J Nutr. 2012;142:592S–599S. doi: 10.3945/jn.111.155259
• 6. McNamara D. Fish Oil Supplements an Issue in Cardiac Surgery. https://www.mdedge.com/familypracticenews/article/30717/cardiology/fish-oil-supplements-issue-cardiac-surgery. 2010. Accessed January 14, 2018.
• 7. Bays HE. Safety considerations with omega-3 fatty acid therapy.Am J Cardiol. 2007;99(6A):35C–43C. doi: 10.1016/j.amjcard.2006.11.020
• 8. Rowe DJ, Baker AC. Perioperative risks and benefits of herbal supplements in aesthetic surgery.Aesthet Surg J. 2009;29:150–157. doi: 10.1016/j.asj.2009.01.002
• 9. Stanford Health Care. Preparing for Mohs Surgery.https://stanfordhealthcare.org/medical-treatments/m/mohs-micrographic-surgery/preparing-for-surgery.html. Accessed January 14, 2018.
• 10. University of Washington Medicine. Medications to Avoid Before Surgery. https://depts.washington.edu/anesth/care/anesthesiology/hmc/meds.shtml. Accessed January 14, 2018.
• 11. WebMD. Surgery Patients Unaware of Herbal Risks.http://www.webmd.com/drug-medication/news/20090416/surgery-patients-unaware-of-herbal-risk#1. Accessed January 14, 2018.
• 12. Harris WS. Expert opinion: omega-3 fatty acids and bleeding-cause for concern?Am J Cardiol. 2007;99(6A):44C–46C. doi: 10.1016/j.amjcard.2006.11.021
• 13. Villani AM, Crotty M, Cleland LG, James MJ, Fraser RJ, Cobiac L, Miller MD. Fish oil administration in older adults with cardiovascular disease or cardiovascular risk factors: is there potential for adverse events? A systematic review of the literature.Int J Cardiol. 2013;168:4371–4375. doi: 10.1016/j.ijcard.2013.05.054
• 14. Thies F, Garry JM, Yaqoob P, Rerkasem K, Williams J, Shearman CP, Gallagher PJ, Calder PC, Grimble RF. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial.Lancet. 2003;361:477–485. doi: 10.1016/S0140-6736(03)12468-3
• 15. Eritsland J, Arnesen H, Grønseth K, Fjeld NB, Abdelnoor M. Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency.Am J Cardiol. 1996;77:31–36.
• 16. DeCaterina R, Giannessi D, Mazzone A, Bernini W, Lazzerini G, Maffei S, Cerri M, Salvatore L, Weksler B. Vascular prostacyclin is increased in patients ingesting omega-3 polyunsaturated fatty acids before coronary artery bypass graft surgery.Circulation. 1990;82:428–438.
• 17. Mozaffarian D, Marchioli R, Macchia A, Silletta MG, Ferrazzi P, Gardner TJ, Latini R, Libby P, Lombardi F, O’Gara PT, Page RL, Tavazzi L, Tognoni G; OPERA Investigators. Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial.JAMA. 2012;308:2001–2011. doi: 10.1001/jama.2012.28733
• 18. Mozaffarian D, Marchioli R, Gardner T, Ferrazzi P, O’Gara P, Latini R, Libby P, Lombardi F, Macchia A, Page R, Santini M, Tavazzi L, Tognoni G. The ω-3 fatty acids for prevention of post-operative atrial fibrillation trial–rationale and design.Am Heart J. 2011;162:56.e3–63.e3. doi: 10.1016/j.ahj.2011.03.035
• 19. Wu JH, Marchioli R, Silletta MG, Macchia A, Song X, Siscovick DS, Harris WS, Masson S, Latini R, Albert C, Brown NJ, Lamarra M, Favaloro RR, Mozaffarian D. Plasma phospholipid omega-3 fatty acids and incidence of postoperative atrial fibrillation in the OPERA trial.J Am Heart Assoc. 2013;2:e000397. doi: 10.1161/JAHA.113.000397
• 20. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.Circulation. 2011;123:2736–2747. doi: 10.1161/CIRCULATIONAHA.110.009449
• 21. Morrow JD, Minton TA. Improved assay for the quantification of 11-dehydrothromboxane B2 by gas chromatography-mass spectrometry.J Chromatogr. 1993;612:179–185.
• 22. Kahan BC, Morris TP. Improper analysis of trials randomised using stratified blocks or minimisation.Stat Med. 2012;31:328–340. doi: 10.1002/sim.4431
• 23. Akintoye E, Wu JH, Hou T, Song X, Yang J, Hammock B, Mozaffarian D. Effect of fish oil on monoepoxides derived from fatty acids during cardiac surgery.J Lipid Res. 2016;57:492–498. doi: 10.1194/jlr.P062398
• 24. Dial S, Delabays E, Albert M, Gonzalez A, Camarda J, Law A, Menzies D. Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass.J Thorac Cardiovasc Surg. 2005;130:654–661. doi: 10.1016/j.jtcvs.2005.02.025
• 25. McDonald SB, Renna M, Spitznagel EL, Avidan M, Hogue CW, Moon MR, Barzilai B, Saleem R, McDonald JM, Despotis GJ. Preoperative use of enoxaparin increases the risk of postoperative bleeding and re-exploration in cardiac surgery patients.J Cardiothorac Vasc Anesth. 2005;19:4–10. doi: 10.1053/j.jvca.2004.11.002
• 26. Nuttall GA, Erchul DT, Haight TJ, Ringhofer SN, Miller TL, Oliver WC, Zehr KJ, Schroeder DR. A comparison of bleeding and transfusion in patients who undergo coronary artery bypass grafting via sternotomy with and without cardiopulmonary bypass.J Cardiothorac Vasc Anesth. 2003;17:447–451.
• 27. Ray JG, Deniz S, Olivieri A, Pollex E, Vermeulen MJ, Alexander KS, Cain DJ, Cybulsky I, Hamielec CM. Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel.BMC Cardiovasc Disord. 2003;3:3.
• 28. Magovern JA, Sakert T, Benckart DH, Burkholder JA, Liebler GA, Magovern GJ, Magovern GJ. A model for predicting transfusion after coronary artery bypass grafting.Ann Thorac Surg. 1996;61:27–32. doi: 10.1016/0003-4975(95)00808-X
• 29. Moskowitz DM, Klein JJ, Shander A, Cousineau KM, Goldweit RS, Bodian C, Perelman SI, Kang H, Fink DA, Rothman HC, Ergin MA. Predictors of transfusion requirements for cardiac surgical procedures at a blood conservation center.Ann Thorac Surg. 2004;77:626–634. doi: 10.1016/S0003-4975(03)01345-6
• 30. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits.JAMA. 2006;296:1885–1899. doi: 10.1001/jama.296.15.1885
• 31. Leon H, Shibata MC, Sivakumaran S, Dorgan M, Chatterley T and Tsuyuki RT. Effect of fish oil on arrhythmias and mortality: systematic review.BMJ (Clinical research ed). 2008;337:a2931.
• 32. Marik PE, Varon J. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.Clin Cardiol. 2009;32:365–372. doi: 10.1002/clc.20604
• 33. Bhatt DL, Steg PG, Brinton EA, Jacobson TA, Miller M, Tardif JC, Ketchum SB, Doyle RT, Murphy SA, Soni PN, Braeckman RA, Juliano RA, Ballantyne CM; REDUCE-IT Investigators. Rationale and design of REDUCE-IT: Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial.Clin Cardiol. 2017;40:138–148. doi: 10.1002/clc.22692
• 34. Nissen S, Lincoff M, Nicholls S. Outcomes study to assess Statin Residual Risk Reduction With Epanova in High CV Risk Patients With Hypertriglyceridemia (STRENGTH). https://clinicaltrialsgov/ct2/show/NCT02104817. Accessed January 14, 2018.
• 35. Siscovick DS, Barringer TA, Fretts AM, Wu JH, Lichtenstein AH, Costello RB, Kris-Etherton PM, Jacobson TA, Engler MB, Alger HM, Appel LJ, Mozaffarian D; American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Epidemiology and Prevention; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology. Omega-3 polyunsaturated fatty acid (fish oil) supplementation and the prevention of clinical cardiovascular disease: a science advisory from the American Heart Association.Circulation. 2017;135:e867–e884. doi: 10.1161/CIR.0000000000000482
• 36. U.S. Food and Drug Administration. Summary of qualified health claims subject to enforcement discretion.https://www.fda.gov/Food/LabelingNutrition/ucm073992.htm. Accessed January 14, 2018.
• 37. Dyerberg J, Bang HO. Haemostatic function and platelet polyunsaturated fatty acids in Eskimos.Lancet. 1979;2:433–435.
• 38. Knapp HR. Dietary fatty acids in human thrombosis and hemostasis.Am J Clin Nutr. 1997;65(5 suppl):1687S–1698S. doi: 10.1093/ajcn/65.5.1687S
• 39. Siess W, Roth P, Scherer B, Kurzmann I, Böhlig B, Weber PC. Platelet-membrane fatty acids, platelet aggregation, and thromboxane formation during a mackerel diet.Lancet. 1980;1:441–444.
• 40. Bradlow BA, Chetty N, van der Westhuyzen J, Mendelsohn D, Gibson JE. The effects of a mixed fish diet on platelet function, fatty acids and serum lipids.Thromb Res. 1983;29:561–568.
• 41. Driss F, Vericel E, Lagarde M, Dechavanne M, Darcet P. Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid.Thromb Res. 1984;36:389–396.
• 42. Lorenz R, Spengler U, Fischer S, Duhm J, Weber PC. Platelet function, thromboxane formation and blood pressure control during supplementation of the Western diet with cod liver oil.Circulation. 1983;67:504–511.
• 43. El-Gendy AA, Abbas AM. Effect of omega-3 fatty acids on haemostatic functions in urocortin-treated obese rats.J Physiol Biochem. 2014;70:809–820. doi: 10.1007/s13105-014-0350-3
• 44. Entrust Medical group. Medications to Avoid before Surgery.http://www.entrustmd.com/webdocuments/medications-to-avoid-binder.pdf. Accessed January 14, 2018.
• 46. Clarke JT, Cullen-Dean G, Regelink E, Chan L, Rose V. Increased incidence of epistaxis in adolescents with familial hypercholesterolemia treated with fish oil.J Pediatr. 1990;116:139–141.
• 47. Goren A, Stankiewicz H, Goldstein R, Drukker A. Fish oil treatment of hyperlipidemia in children and adolescents receiving renal replacement therapy.Pediatrics. 1991;88:265–268.
• 48. Janssen MJ, van der Meulen J. The bleeding risk in chronic haemodialysis: preventive strategies in high-risk patients.Neth J Med. 1996;48:198–207.
• 49. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K; Japan EPA lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.Lancet. 2007;369:1090–1098. doi: 10.1016/S0140-6736(07)60527-3
• 50. Farquharson AL, Metcalf RG, Sanders P, Stuklis R, Edwards JR, Gibson RA, Cleland LG, Sullivan TR, James MJ, Young GD. Effect of dietary fish oil on atrial fibrillation after cardiac surgery.Am J Cardiol. 2011;108:851–856. doi: 10.1016/j.amjcard.2011.04.036
• 51. Metcalf RG, James MJ, Gibson RA, Edwards JR, Stubberfield J, Stuklis R, Roberts-Thomson K, Young GD, Cleland LG. Effects of fish-oil supplementation on myocardial fatty acids in humans.Am J Clin Nutr. 2007;85:1222–1228. doi: 10.1093/ajcn/85.5.1222
• 53. Weerasinghe A, Taylor KM. The platelet in cardiopulmonary bypass.Ann Thorac Surg. 1998;66:2145–2152.
• 55. Meredith DS, Kepler CK, Huang RC, Hirsch B, Nguyen J, Farmer JC, Girardi FP, O’Leary PF, Cammisa FP. The effect of omega-3 fatty-acid supplements on perioperative bleeding following posterior spinal arthrodesis.Eur Spine J. 2012;21:2659–2663. doi: 10.1007/s00586-012-2365-1
• 56. Nunez D, Randon J, Gandhi C, Siafaka-Kapadai A, Olson MS, Hanahan DJ. The inhibition of platelet-activating factor-induced platelet activation by oleic acid is associated with a decrease in polyphosphoinositide metabolism.J Biol Chem. 1990;265:18330–18338.
• 57. Barradasa MA, Christofides JA, Jeremya JY, Mikhailidisa DP, Fry DE, Dandona P. The effect of olive oil supplementation on human platelet function, serum cholesterol-related variables and plasma fibrinogen concentrations: a pilot study.Nutrition Research. 1990;10:403–411.
• 58. The Olive Oil Source. Chemical Characteristics of Olive Oil. https://www.oliveoilsource.com/page/chemical-characteristics. Accessed January 14, 2018.
• 59. Ervin RB, Wright JD, Wang CY, Kennedy-Stephenson J. Dietary intake of fats and fatty acids for the United States population: 1999–2000.Advance data. 2004;8:1–6.